ERBB2 and breast cancer: Higher concentrations of tumor-infiltrating lymphocytes (TILs), lymphocytes that migrate into the tumor microenvironment, have been associated with better prognosis and treatment response in BC, especially in two subtypes: HER2-positive and triple-negative breast cancer (TNBC) [10, 11].